Covered recipient · General Payments record
KATHRYN M ACCARDO
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,504.45
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $475.47 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $327.58 | 15 |
| Galderma Laboratories, L.P. | $109.84 | 2 |
| Novo Nordisk AS | $21.79 | 1 |
| INTRA-SANA LABORATORIES | $16.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.33 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407419 | CMS |
| ABBVIE INC. | $8.31 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407421 | CMS |
| ABBVIE INC. | $4.19 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407423 | CMS |
| ABBVIE INC. | $13.98 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407425 | CMS |
| ABBVIE INC. | $24.34 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407427 | CMS |
| ABBVIE INC. | $20.21 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407429 | CMS |
| ABBVIE INC. | $115.00 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407431 | CMS |
| ABBVIE INC. | $9.53 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407433 | CMS |
| ABBVIE INC. | $18.10 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407435 | CMS |
| ABBVIE INC. | $2.03 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407437 | CMS |
| ABBVIE INC. | $14.44 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407439 | CMS |
| ABBVIE INC. | $6.44 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407441 | CMS |
| ABBVIE INC. | $14.29 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407443 | CMS |
| ABBVIE INC. | $13.10 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407445 | CMS |
| ABBVIE INC. | $31.29 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106407447 | CMS |
| Galderma Laboratories, L.P. | $26.92 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145337949 | CMS |
| Galderma Laboratories, L.P. | $82.92 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145337951 | CMS |
| Intra-Sana Laboratories | $16.26 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138620842 | CMS |
| Novo Nordisk Inc | $21.79 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100554723 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.